DNA, ROI, and new technology that can reduce treatment costs and improve outcomes.
Mark Manquen
Advertisement
Articles by Mark Manquen
Advertisement
Latest Updated Articles
The Pharmacogenomic FrontierPublished: December 16th 2019 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
HS patients on biosimilar adalimumab lose response faster than those on the original drug
2
CMS negotiates a 70% discount for Ozempic and Wegovy
3
Global MS analysis links disability burden to rising economic strain
4
New drug class shows promise for geographic atrophy
5
